Literature DB >> 15108065

Impaired gamma carboxylation of osteocalcin in elderly women with type II diabetes mellitus: relationship between increase in undercarboxylated osteocalcin levels and low bone mineral density.

Toshiyuki Horiuchi1, Hirohito Kazama, Atsushi Araki, Junichiro Inoue, Takayuki Hosoi, Tsuneko Onouchi, Shouichi Mizuno, Hideki Ito, Hajime Orimo.   

Abstract

We conducted a cross-sectional examination of the role of serum vitamin K levels as they relate to bone metabolism in elderly women with type II diabetes mellitus (DM). Eighty-five elderly women with type II DM were enrolled. Three fractions of vitamin K, phylloquinone (PK), menaquinone 4 (menatetrenone; MK 4), and menaquinone 7 (MK 7), along with undercarboxylated osteocalcin (UcOC), intact osteocalcin (IOC), urinary deoxypyridinoline (udpd), urinary type I collagen N-telopeptide (NTx), and intact parathyroid hormone (IPTH) were measured. Bone mineral density was measured in the lumbar spine (LSBMD) by dual-energy X-ray absorptiometry (DXA), and T scores or Z scores were calculated. The patients were divided into two groups by T score, under -2.5 (osteoporotic group) and over -2.5 (non-osteoporotic group). UcOC levels in osteoporotics patients were significantly higher than those in the non-osteoporotic group (3.09 +/- 3.94 vs 1.82 +/- 1.76 ng/ml, P = 0.02). The correlation between Z score and logarithmic UcOC/IOC levels in type II DM showed a negative trend ( P = 0.07) and a significantly and negatively association with logarithmic NTx ( r = -0.38; P = 0.001). In osteoporotic DM, the UcOC/IOC ratio was significantly correlated with the Z score ( r = -0.61; P << 0.05). Furthermore, logarithmic UcOC/IOC showed a negative correlation with logarithmic MK 7 ( r = -0.50; P = 0.001). In conclusion, the reduction in LSBMD in elderly women with type II DM may be associated, in part, with a defect in Gamma-glutamylcarboxylation by vitamin K.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108065     DOI: 10.1007/s00774-003-0473-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  7 in total

1.  Warfarin and calcific uremic arteriolopathy.

Authors:  Peter John Torquil Balfour; Peter Rose
Journal:  BMJ Case Rep       Date:  2009-12-03

Review 2.  Regulation of bone remodeling by vitamin K2.

Authors:  V D Myneni; E Mezey
Journal:  Oral Dis       Date:  2017-04-05       Impact factor: 3.511

Review 3.  Bone and glucose metabolism: a two-way street.

Authors:  Katherine J Motyl; Laura R McCabe; Ann V Schwartz
Journal:  Arch Biochem Biophys       Date:  2010-08-01       Impact factor: 4.013

4.  Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome.

Authors:  Evanthia Diamanti-Kandarakis; Sarantis Livadas; Ilias Katsikis; Christine Piperi; Aimilia Mantziou; Mantziou Aimilia; Athanasios G Papavassiliou; Dimitrios Panidis
Journal:  J Bone Miner Metab       Date:  2010-08-07       Impact factor: 2.626

5.  Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism.

Authors:  Ali Movahed; Bagher Larijani; Iraj Nabipour; Mohammadreza Kalantarhormozi; Kamyar Asadipooya; Katayoun Vahdat; Samad Akbarzadeh; Maryam Farrokhnia; Majid Assadi; Roya Amirinejad; Afshar Bargahi; Zahra Sanjdideh
Journal:  J Bone Miner Metab       Date:  2012-07-03       Impact factor: 2.626

6.  Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis.

Authors:  Yuji Kasukawa; Naohisa Miyakoshi; Toshihito Ebina; Toshiaki Aizawa; Michio Hongo; Koji Nozaka; Yoshinori Ishikawa; Hidetomo Saito; Shuichi Chida; Yoichi Shimada
Journal:  J Bone Miner Metab       Date:  2013-07-12       Impact factor: 2.626

7.  Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study.

Authors:  Yang Xu; Li Shen; Lianyong Liu; Zhenlin Zhang; Weiwei Hu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-08       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.